https://doctransparency.com/doctor/fl/miami/manuel-abella-1023095403
Medicare Enrolled

Dr. Manuel Abella, M.D

Cardiovascular Disease · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
8200 SW 117TH AVENUE, Miami, FL 33183
3052216161
In practice since 2005 (20 years)
NPI: 1023095403 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abella? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abella

Dr. Manuel Abella is a cardiovascular disease in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Abella performed 270 Medicare services across 160 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abella received a total of $14,971 from 12 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abella is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 270 Medicare services$ $14,971 industry payments

Medicare Practice Summary

Medicare Utilization ↗
270
Medicare services
Bottom 8% in FL for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
160
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)181$97$174
Electrocardiogram (EKG), 12-lead31$12$31
Ultrasound study of arm or leg veins with compression and maneuvers20$150$312
Echocardiogram, transthoracic19$160$301
New patient office visit (45-59 min)19$128$275
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
7.4% medium
85.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,971
Total received (2018-2024)
Avg $2,139/year across 7 years
Top 17% in FL for cardiovascular disease
12
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$7,920 (52.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,574 (43.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$477 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,818
2023
$3,209
2022
$180
2021
$19
2020
$2,000
2019
$171
2018
$4,573

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$7,920
Medtronic Vascular, Inc.
$4,562
Venclose Inc.
$2,142
Bard Peripheral Vascular, Inc.
$180
Medtronic, Inc.
$46
ABBVIE INC.
$26
E.R. Squibb & Sons, L.L.C.
$25
Lilly USA, LLC
$19
Cardiovascular Systems Inc.
$17
Regeneron Healthcare Solutions, Inc.
$12
Novo Nordisk Inc
$12
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 97.7% of total payments
Associated products mentioned in payments ›
ClosureFast · ELIQUIS · Ozempic · PRALUENT · Peripheral Orbital Atherectomy System · TRULICITY · UBRELVY · VENASEAL · VenaCure 1470 Pro · VenaSeal · Venclose · Venclose Maven Catheter · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Equivalent to $5,545 per 100 Medicare services performed
Looking for a cardiovascular disease in Miami?
Compare cardiovascular diseases in the Miami area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
323
Per 100K population
12.0
County median income
$68,694
Nearest hospital
HCA FLORIDA KENDALL HOSPITAL
2.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abella is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 17%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Abella experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Abella performed 181 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abella receive payments from pharmaceutical companies?
Yes. Dr. Abella received a total of $14,971 from 12 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abella's costs compare to other cardiovascular diseases in Miami?
Dr. Abella's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →